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Manipulative Therapy in Addition to Usual Medical Care for Patients
with Shoulder Dysfunction and Pain
A Randomized, Controlled Trial
Gert J.D. Bergman, MSc; Jan C. Winters, PhD, MD; Klaas H. Groenier, MSc; Jan J.M. Pool; Betty Meyboom-de Jong, PhD, MD;
Klaas Postema, PhD, MD; and Geert J.M.G. van der Heijden, PhD
Background: Dysfunction of the cervicothoracic spine and the
adjacent ribs (also called the shoulder girdle) is considered to
predict occurrence and poor outcome of shoulder symptoms. It
can be treated with manipulative therapy, but scientific evidence
for the effectiveness of such therapy is lacking.
Objective: To study the effectiveness of manipulative therapy
for the shoulder girdle in addition to usual medical care for relief
of shoulder pain and dysfunction.
Design: Randomized, controlled trial.
Setting: General practices in Groningen, the Netherlands.
Patients: 150 patients with shoulder symptoms and dysfunction
of the shoulder girdle.
Interventions: All patients received usual medical care from
their general practitioners. Only the intervention group received
additional manipulative therapy, up to 6 treatment sessions in a
12-week period.
Measurements: Patient-perceived recovery, severity of the main
complaint, shoulder pain, shoulder disability, and general health.
Data were collected during and at the end of the treatment period
(at 6 and 12 weeks) and during the follow-up period (at 26 and
52 weeks).
Results: During treatment (6 weeks), no significant differences
were found between study groups. After completion of treatment
(12 weeks), 43% of the intervention group and 21% of the
control group reported full recovery. After 52 weeks, approxi-
mately the same difference in recovery rate (17 percentage points)
was seen between groups. During the intervention and follow-up
periods, a consistent between-group difference in severity of the
main complaint, shoulder pain and disability, and general health
favored additional manipulative therapy.
Limitations: The sample size was small, and assessment of end
points was subjective.
Conclusion: Manipulative therapy for the shoulder girdle in
addition to usual medical care accelerates recovery of shoulder
symptoms.
Ann Intern Med. 2004;141:432-439. www.annals.org
For author affiliations, see end of text.
Shoulder disorders are a widely recognized medical, so-cial, and economic problem (1). They are characterized
by functional disability due to pain in the shoulder at rest
or during movement or by functional disability due to
restricted range of motion. The annual incidence of shoul-
der symptoms in Dutch general medical practices is esti-
mated to be 10 to 25 per 1000 enrolled patients (2–4).
In the Netherlands, shoulder disorders are treated ac-
cording to the Guidelines for Shoulder Complaints of the
Dutch College of General Practitioners (5, 6). Initial treat-
ment during the first 2 weeks includes informing patients
about the nature and course of shoulder symptoms and
advising them on how to use the affected shoulder during
daily living. Patients can also be prescribed analgesics or
nonsteroidal anti-inflammatory drugs if necessary. If this
initial treatment is not effective, up to 3 corticosteroid
injections (in the subacromial space or glenohumeral joint)
can be given. Referral for physiotherapy is considered only
for patients whose symptoms persist for 6 weeks or more.
This treatment regimen, according to the guidelines, pro-
vides short-term benefit for many patients but cannot pre-
vent the often unfavorable long-term course of the symp-
toms. Indeed, only 50% of all new episodes of shoulder
disorders resolve within 6 months, while at 12 months
more than 40% of all patients are still disabled during
work and leisure time (4, 7).
Pain or dysfunction of the cervicothoracic spine and
the adjacent ribs (also called the shoulder girdle) often ac-
companies shoulder symptoms (8). A considerable propor-
tion of patients with shoulder symptoms (approximately
20%) but no shoulder joint disorders may be found to
have dysfunction of the shoulder girdle on further physical
examination (9). Moreover, dysfunction of the shoulder
girdle triples the risk for shoulder complications (10) and
also predicts poor outcome of shoulder disorders (10–12).
In clinical practice, dysfunction of the shoulder girdle can
be treated with manipulative therapy, which aims to re-
store normal function. Winters and colleagues (13) found
that manipulative therapy accelerated recovery and im-
proved symptoms compared with physiotherapy in a rela-
tively small subgroup of patients with both shoulder symp-
toms and shoulder girdle dysfunction. These effects were
not sustained on long-term follow-up, possibly because of
high attrition rates (14).
Evidence showing that manipulative therapy for the
shoulder girdle effectively treats shoulder symptoms is
scarce; Winters and colleagues have performed the only
randomized trial (13, 14) to date. Our objective was to
study the effectiveness of manipulative therapy for the
shoulder girdle in addition to usual medical care by a gen-
eral practitioner. The study design has been described else-
where (15), and the trial was designed and reported accord-
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ing to the Consolidated Standards of Reporting Trials
(CONSORT) statement (16). We report the effects of the
use of additional manipulative therapy for the shoulder
girdle to treat shoulder symptoms.
METHODS
Participants
Potential eligible participants with shoulder symptoms
(pain and dysfunction) were recruited in 50 general prac-
tices in Groningen, the Netherlands. General practitioners
started initial treatment (usual medical care) at presenta-
tion, assessed eligibility criteria, and told the conducting
researcher about each eligible patient. The general practi-
tioner used a standardized eligibility checklist and a phys-
ical examination as recommended by the Dutch College of
General Practitioners (5, 6). A baseline assessment at the
research center was scheduled within 2 weeks of presenta-
tion. Shoulder symptoms were defined as pain between the
neck and the elbow at rest or during movement of the
upper arm (Figure 1). Pain radiating to the neck region or
to the lower part of the arm was not used as an exclusion
criterion. The physical examination established the pres-
ence of both shoulder symptoms and dysfunction of the
cervicothoracic spine and the adjacent ribs with accompa-
nying pain or restricted movement. Eligible patients were
18 years of age or older and had had no consultation or
treatment for shoulder symptoms in the past 3 months. No
limits were placed on duration of symptoms before the first
consultation.
Reasons for exclusion were acute severe trauma, such
as fractures, ruptures, or dislocation in the shoulder region;
previous orthopedic surgery; clear treatment preference de-
viating from the study protocol; contraindications to ma-
nipulative therapy (for example, hypermobility, instability,
or severe arthrosis of the cervicothoracic spine); signs of
cervical nerve root compression; presence of specific rheu-
matic disorders; presence of dementia or other severe psy-
chiatric, emotional, or behavioral disorders; shoulder dis-
orders due to general internal disease of thoracic and
abdominal organs; and inability to complete Dutch-
language written questionnaires. Eligibility and exclusion
criteria were verified before randomization by using a
structured medical history and physical assessment.
Randomization
Patients were evenly allocated to receive manipulative
therapy plus usual medical care or usual medical care alone.
An independent statistician not involved in recruitment of
patients generated a random list that was stratified for gen-
eral practitioner by permutation of randomized blocks,
with a block size of 6. After eligibility was verified, written
informed consent was obtained. A researcher opened
preprepared numbered, opaque sealed envelopes contain-
ing the treatment allocation codes and made appointments
with manual therapists when applicable.
Interventions
Usual Medical Care
All patients received usual medical care from their gen-
eral practitioners. Usual medical care was similar to that
outlined by the Dutch College of General Practitioners (5,
6) and included information, advice, and therapy. During
the first 2 weeks, patients were given information about the
nature and course of shoulder symptoms, along with advice
on daily use of the affected shoulder. Patients were pre-
scribed oral analgesics or nonsteroidal anti-inflammatory
drugs if necessary. The Dutch College of General Practi-
tioners recommends 2 weeks of treatment with paraceta-
mol, 4 times daily (maximum dosage, 4000 mg/d), or non-
steroidal anti-inflammatory drugs such as ibuprofen, 3
times daily (maximum dosage, 2400 mg/d); diclofenac, 3
times daily (maximum dosage, 150 mg/d); or naproxen,
twice daily (maximum dosage, 1000 mg/d) (5, 6). If pa-
tients did improve, drug treatment could be extended for
another 2 weeks. If this approach was ineffective, up to 3
Figure 1. Location of shoulder symptoms.
Context
Shoulder pain in the absence of trauma, fracture, rupture,
or dislocation can lead to substantial functional limitations
and can be a difficult condition to treat.
Contribution
In this randomized, controlled trial, patients with shoulder
pain and shoulder girdle dysfunction assigned to receive
manipulative therapy in addition to usual general practi-
tioner care had more rapid improvement in symptoms and
fewer shoulder symptoms at 12 weeks than patients as-
signed to usual care alone.
Implications
Manipulative therapy appears to be an effective treatment
option for patients with shoulder pain and shoulder girdle
dysfunction that are not due to trauma, fracture, rupture,
or dislocation.
–The Editors
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corticosteroid injections could be given in either the sub-
acromial space or the glenohumeral joint. For injections in
either location, physicians used triamcinolone acetonide,
40 mg suspended in a 1-mL vehicle, if necessary, combined
with lidocaine, 10 mg suspended in a 5- to 10-mL vehicle.
If improvement remained insufficient 2 weeks after injec-
tions were given, injections could be repeated. Further cor-
ticosteroid treatment was not considered appropriate if pa-
tients did not improve after the second series of injections.
For symptoms persisting at least 6 weeks, physiotherapy
consisting of shoulder exercises, massage, and physical ap-
plications was considered. Other referrals during the inter-
vention and follow-up periods (for example, to a rheuma-
tology consultant or orthopedic surgeon) were discouraged
but were documented if they occurred.
Manipulative Therapy
According to the International Federation of Orthope-
dic Manipulative Therapists, “orthopedic manipulative
(manual) therapy is a specialization within physical therapy
and provides comprehensive conservative management for
pain and other symptoms of neuro-musculo-articular dys-
function in the spine and extremities.” Our approach to
manipulative therapy focused on manual manipulation and
mobilization techniques used in western Europe, North
America, and Australia, including those described by
Cyriax (17), Greenman (18), and Lewit (19). In our trial,
manipulative therapy included specific manipulations
(low-amplitude, high-velocity thrust techniques) and spe-
cific mobilizations (high-amplitude, low-velocity thrust
techniques) to improve overall joint function and decrease
any restrictions in movement at single or multiple segmen-
tal levels in the cervical spine and upper thoracic spine and
adjacent ribs. The manual therapist chose the applied tech-
niques on the basis of the location of the dysfunction and
the therapist’s technique preferences. Within the bound-
aries of the protocol, treatment could be reassessed and
adapted to the patient’s condition.
A maximum of 6 treatment sessions could be given
over a 12-week period. Eight experienced physiotherapists
who were members of the Dutch Association of Manual
Therapy and registered by the Royal Dutch Society for
Physical Therapy (a member of the International Federa-
tion of Orthopedic Manipulative Therapists) provided the
manual therapy. To minimize variations in manipulative
therapy, therapists received a special training session to fa-
miliarize them with the protocol’s mobilization and ma-
nipulation techniques for treatment of the cervicothoracic
spine and the adjacent ribs. Other interventions (for exam-
ple, exercises, massage, advice about posture, and treatment
of the shoulder joint) were considered deviations from the
treatment protocol and were therefore discouraged
throughout the trial. Specific treatment characteristics and
protocol deviations were recorded at each visit.
Outcomes
Outcome measures were recorded at baseline, at 6
weeks (during the intervention period), and at 12 weeks (at
completion of the intervention period). The primary out-
come measure was patient-perceived recovery. Patients
were considered recovered if they reported being “com-
pletely recovered” or “very much improved” on a 7-point
ordinal scale. In addition, patients were asked whether they
felt “cured” according to the following definition: “You are
considered cured if your shoulder symptoms are improved
to such an extent that you no longer perceive them as
inconvenient.” Secondary outcomes included the severity
of 3 individual main complaints (20), shoulder pain (21),
functional disability (22), general health (23), and costs
(costs data not yet available) (24). The main complaint is
defined as an unavoidable painful or limited functional
activity during daily life in which the shoulder is involved.
It is a patient-specific or individualized approach for mea-
suring limitation of shoulder function during daily activi-
ties. During each session, manual therapists and general
practitioners documented the treatment content on a stan-
dardized registration form.
Sample Size
Sample size was calculated on the basis of an assumed
proportion of 50% of patients without shoulder symptoms
in the control group at 6 months, a 2-sided  value of
0.05, a statistical power of 0.80, and an attrition rate of
10%. According to these assumptions, a sample size of 250
patients (125 in each treatment group) would be needed to
detect a between-group difference of 20 percentage points
(15).
Blinding
Manipulative therapy is an open-label treatment for
which patients, general practitioners, and manual thera-
pists cannot be blinded. The research assistants responsible
for the follow-up measurements were blinded to the allo-
cated treatment. General practitioners were not informed
about patients’ treatment allocation until completion of
the intervention period. Each manual therapist received a
letter containing information about the participating pa-
tient and a schedule for treatments and for assessments
during the follow-up period. Patients were instructed not
to inform the research assistants or the general practitioners
about the received treatment.
Statistical Analysis
All data analyses based on treatment assignment (the
intention-to-treat principle) were performed according to a
predetermined protocol. The baseline status of the study
groups was compared with respect to the distribution of all
independent prognostic variables and the baseline values of
the outcome variables. Differences between groups and
95% CIs were calculated for each outcome measure ac-
cording to the intention-to-treat principle. Mean changes
between study groups were compared by using an indepen-
dent-samples t-test (for continuous outcome variables) and
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the chi-square test (for categorical outcome variables). In-
fluences of prognostic indicators on outcomes of manipu-
lative therapy were assessed in a multivariate logistic regres-
sion analysis. Only a 2-sided significance test was used
(  0.05). All analyses were done by using SPSS statisti-
cal software, version 11.0 (SPSS, Inc., Chicago, Illinois).
We used unconditional mean single imputation to re-
place missing data for covariates. Prognostic status at base-
line for patients with and without missing values for the
outcome variables was compared for the study sample and
by treatment group. We present results with missing values
for outcome variables replaced by the previous available
value (last value carried forward) and report on the analysis
in which missing values were replaced by the baseline value
(baseline value carried forward).
The Medical Ethics Committee of the University Hos-
pital of Groningen, Groningen, the Netherlands, approved
the study protocol.
Role of the Funding Sources
The funding sources approved the study design but
played no part in conducting or reporting the study.
RESULTS
Recruitment and Follow-up
Three hundred eighty-eight patients were referred to
the research center, and 150 participated in the trial. Rea-
sons for exclusion are given in Figure 2. Seventy-one pa-
tients were assigned to the control group, and 79 were
assigned to the intervention group. Because 1 patient in
the control group did not return the baseline question-
naire, the prognosis for this patient was not available for
some variables. In total, 32 patients (16 per treatment
Figure 2. Flow of patients through the study.
*Percentage of patients who received the intervention (wait-and-see policy along with injection therapy and physiotherapy). GP general practitioner.
ArticleManipulative Therapy for Patients with Shoulder Pain and Dysfunction
www.annals.org 21 September 2004 Annals of Internal Medicine Volume 141 • Number 6 435
group) had data missing for at least 1 outcome variable. In
the control group, 55 patients (78%) had data available for
all outcome measures, 8 patients (11%) had missing data
for fewer than 25% of outcome measures, and 8 patients
(11%) had missing data for more than 25% of outcome
measures. In the intervention group, the corresponding
numbers were 63 patients (80%), 10 patients (13%), and 6
patients (8%), respectively. Patients who missed appoint-
ments for outcome assessments had many missing values
for outcome variables. In the control group, 5 patients
discontinued treatment because of lack of motivation
(n  3), lack of time (n  1), and a car accident (n  1),
and 1 patient dropped out during the follow-up period
because of lack of motivation. In the intervention group, 3
patients discontinued treatment because of lack of motiva-
tion (n  2) and family circumstances (n  1), and 1
patient withdrew from follow-up because of lack of moti-
vation.
In general, patients with 1 or more missing value for
outcome variables had shorter pain episodes and more pre-
vious pain episodes and rated their main complaint as
more severe at baseline. Among patients who had complete
data for outcome variables, we compared patients whose
prognoses were similar to those of patients with missing
data and those who prognoses were different. Main out-
come measures were similar in both groups.
Baseline Characteristics
Baseline status (patient characteristics and baseline val-
ues of the outcome measures) is given in Table 1. Both
groups were highly similar in demographic and prognostic
variables and baseline values of outcome measures.
Treatment during the Intervention Period
Patients consulted their general practitioners a mean of
2.4 times. There was a small difference between the control
group and the intervention group in mean number of visits
(2.3 vs. 2.5 visits). Ninety-two percent of controls were
treated with a wait-and-see policy, 28% were treated with
corticosteroid injections (mean, 1.6 injections), and 27%
were referred to a physical therapist for a maximum of 9
treatment sessions. In the intervention group, these per-
centages were 96%, 25% (mean, 2.1 injections), and 23%,
respectively (Figure 2).
Patients in the intervention group received a mean
(SD) of 3.8 1.5 treatment sessions from a manual
therapist. In each treatment session, different manipulation
techniques (mean [SD], 1.9 1.1) and mobilization
techniques (mean [SD], 1.1 0.9) were performed. The
mean duration (SD) of a manipulative therapy session
was 23  13 minutes. In 16% of all sessions of manipula-
tive therapy, a manipulative technique was applied on a
joint or vertebral segment outside the shoulder girdle.
Effectiveness of the Interventions
Outcomes after Randomization at 6 and 12 Weeks
Consistently, for all outcome variables, the 6-week
outcomes for the intervention group were similar to the
12-week outcomes for controls (Table 2). Measurements at
6 and 12 weeks showed a consistent difference in favor of
additional manipulative therapy, but none of the differ-
ences at 6 weeks reached statistical significance. At 12
weeks after randomization, statistically significantly more
patients in the intervention group reported full recovery or
very large improvement than did patients in the control
group (difference, 22 percentage points [95% CI, 6.9 to
35.4 percentage points]). In addition, a significant
between-group difference was seen at 12 weeks for mean
improvement in severity of the main complaint (difference,
1.5 points [CI, 0.5 to 2.5 points] on an 11-point scale) and
shoulder pain (difference, 2.0 points [CI, 0.3 to 3.7 points]
on a 21-point scale). The outcomes of shoulder disability
and general health favored additional manipulative ther-
Table 1. Baseline Characteristics and Outcome Measures
according to Treatment Group
Variable Patients Receiving
Usual Medical





Therapy (n  79)
Mean age  SD, y 47.8  11.8 48.4  12.4
Women, n (%) 37 (52) 42 (53)
Dominant side affected, n (%) 45 (63) 58 (73)
Acute onset of symptoms, n (%) 19 (27) 27 (34)
Mean duration of symptoms
before consultation, n (%)
6 wk 28 (39) 28 (35)
6–12 wk 22 (31) 25 (32)
12–26 wk 11 (15) 10 (13)
26 wk 10 (14) 16 (20)
Previous episodes of shoulder
pain, n (%)
None 18 (25) 18 (23)
1 episode 14 (20) 18 (23)
2–5 episodes 27 (38) 27 (34)
5 episodes 12 (17) 16 (20)
Previous neck symptoms, n (%) 43 (61) 50 (63)
Treatment preference regarding
manual therapy, n (%)
Negative 4 (6) 4 (5)
No preference 42 (59) 57 (72)
Positive 25 (35) 18 (23)
Mean severity of main
complaint  SD† 6.4  2.1 6.9  1.9
Mean severity of shoulder pain‡ 17.9  4.3 17.8  4.7
Mean severity of shoulder
disability§ 60.7  29.0 58.6  28.0
General health rating 0.68  0.18 0.69  0.19
* One patient did not return his baseline questionnaire; missing data were replaced
by group means.
† Patient rating of the severity of the main complaint during the preceding week
on an 11-point scale (0  best; 10  worst).
‡ Patient rating of pain at rest, pain in motion, nightly pain, sleeping problems
caused by pain, inability to lie on the painful side, degree of radiation, and general
pain on 4-point ordinal scales (1 no pain; 4 severe pain. Total range:
7  best; 28  worst).
§ Patient rating on Shoulder Disability Questionnaire for the functional status of
the shoulder in the preceding 24 hours (16 items with possible responses of not
applicable, yes, and no). The presented score is the percentage of positive items in
the total applicable items (total range: 0  best; 100  worst).
 EuroQol health-related quality-of-life instrument (5 items on a 3-point ordinal
scale; total range: 1  worst; 1  best).
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apy, but the difference did not reach statistical significance
at 6 or 12 weeks.
Outcomes at 26 and 52 Weeks after Randomization
During follow-up, more patients from the interven-
tion group reported full recovery or very large improve-
ment. The intervention and control groups differed signif-
icantly in perceived recovery (difference, 17 percentage
points [CI, 0.0 to 31.4 percentage points]) and patients
who reported feeling cured (17 percentage points [CI, 1.2
to 32.1 percentage points]) at 52 weeks. The main com-
plaint was significantly less severe in patients treated with
manipulative therapy at 26 weeks and at 52 weeks after
randomization (between-group difference, 1.2 points [CI,
0.2 to 2.2 points] and 1.4 points [CI, 0.4 to 2.4 points],
respectively, on an 11-point scale). The outcomes of shoul-
der pain and disability consistently favored additional ma-
nipulative therapy; however, only shoulder disability
reached a statistically significant difference at 26 weeks
(difference, 12.7 points [CI, 1.3 to 24.1 points] on a 100-
point scale).
Adjustment of the analysis for age, sex, treatment pref-
erence, duration of symptoms before consultation, onset of
symptoms, previous shoulder symptoms, and previous
neck symptoms did not change any of the outcomes. How-
ever, there appeared to be a differential effect across man-
ual therapists. Regardless of prognostic status, patient re-
covery rates for individual therapists ranged from 14% to
67% at the end of the intervention period (12 weeks) and
from 14% to 83% at the end of the follow-up period (52
weeks). However, a chi-square test showed no significant
effects across therapists.
Table 2. Mean Improvement and Differences between Groups in Primary and Secondary Outcome Measures
Outcome Measure Patients Receiving
Usual Medical





Therapy (n  79)
Between-Group
Difference (95% CI)*
Patient-perceived recovery, n/n (%)†
Patients “recovered” at 6 wk 10/71 (14) 16/79 (20) 6 (6.2 to 18.1)
Patients “recovered” at 12 wk 15/71 (21) 34/79 (43) 22 (6.9 to 35.4)
Patients “recovered” at 26 wk 25/71 (35) 32/79 (41) 5 (10.1 to 20.2)
Patients “recovered” at 52 wk 25/71 (35) 41/79 (52) 17 (0 to 31.4)
Patients “cured” at 6 wk 13/71 (18) 19/79 (24) 6 (7.5 to 18.5)
Patients “cured” at 12 wk 24/71 (34) 36/79 (46) 12 (3.9 to 26.5)
Patients “cured” at 26 wk 29/71 (41) 41/79 (52) 11 (4.8 to 26.2)
Patients “cured” at 52 wk 30/71 (42) 47/79 (59) 17 (1.2 to 32.1)
Mean improvement ± SD in severity of main complaint‡
6 wk 2.2  3.2 3.1  3.0 0.9 (0.1 to 1.9)
12 wk 2.9  3.4 4.4  3.0 1.5 (0.5 to 2.5)
26 wk 3.5  3.3 4.7  3.1 1.2 (0.2 to 2.2)
52 wk 3.6  3.4 5.0  2.9 1.4 (0.4 to 2.4)
Mean improvement ± SD in severity of shoulder pain§
6 wk 2.8  4.4 3.6  4.5 0.8 (0.6 to 2.3)
12 wk 3.7  5.2 5.7  5.1 2.0 (0.3 to 3.7)
26 wk 5.2  5.5 5.9  5.3 0.7 (1.0 to 2.5)
52 wk 5.5  5.5 6.7  5.4 1.2 (0.5 to 3.0)
Mean improvement ± SD in shoulder disability
6 wk 11.3  30.0 16.8  21.3 5.5 (2.9 to 13.8)
12 wk 18.2  32.4 26.6  32.3 8.5 (2.0 to 18.9)
26 wk 20.3  35.9 33.0  34.6 12.7 (1.3 to 24.1)
52 wk 27.7  38.9 36.3  35.7 6.9 (3.5 to 20.7)
Mean improvement ± SD in general health¶
6 wk 0.03  0.18 0.07  0.18 0.04 (0.01 to 0.10)
12 wk 0.16  0.25 0.09  0.28 0.06 (0.03 to 0.15)
26 wk 0.08  0.21 0.11  0.19 0.03 (0.04 to 0.09)
52 wk 0.12  0.25 0.12  0.19 0.00 (0.07 to 0.08)
* Values for differences between percentages are expressed as percentage points.
† Patient-perceived recovery. Possible responses for recovery were “recovered,” “completely recovered (yes or no),” or “very large improvement” on a 7-point ordinal scale
ranging from very much improved to very much deteriorated. “Cured” was determined as follows: “You are considered cured if your shoulder symptoms are improved to such
an extent that you no longer perceive them as inconvenient (yes/no).”
‡ Patient rating of the severity of the main complaint during the preceding week on an 11-point scale (0  best; 10  worst).
§ Patient rating of pain at rest, pain in motion, nightly pain, sleeping problems caused by pain, inability to lie on the painful side, degree of radiation, and general pain on
4-point ordinal scales (1  no pain; 4  severe pain. Total range: 7  best; 28  worst).
 Patient rating on Shoulder Disability Questionnaire for the functional status of the shoulder in the preceding 24 hours (16 items with possible responses of not applicable,
yes, and no). The presented score is the percentage of positive items in the total applicable items (total range: 0  best; 100  worst).
¶ EuroQol health-related quality-of-life instrument (5 items on a 3-point ordinal scale; total range: 1  worst; 1  best).
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Alternative Analysis
We performed an alternative analysis that replaced
missing data according to the baseline-value-carried-forward
method. In general, the results (magnitude and SE of be-
tween-group differences) were very similar to those of the
analysis performed according to the last-value-carried-forward
method. However, for patients who reported feeling cured,
the between-group difference at 12 weeks reached statistical
significance (16 percentage points [CI, 0.4 to 30.4 percentage
points]), although the between-group difference at 52 weeks
for the proportion of patients reporting full recovery or very
large improvement did not (15 percentage points [CI, 0.0
to 30.2 percentage points]).
DISCUSSION
In our study, manipulative therapy for the cervicotho-
racic spine and the adjacent ribs in addition to usual med-
ical care by a general practitioner accelerated recovery of
shoulder symptoms. At 12 weeks after randomization, we
found a statistically significant difference in recovery rate
(43% vs. 21%; difference, 22 percentage points [CI, 6.9 to
35.4 percentage points]) in favor of additional manipula-
tive therapy. Other outcome measures, such as shoulder
pain and shoulder disability, consistently favored addi-
tional manipulative therapy, supporting our main finding.
These favorable effects were maintained during the
follow-up period. At 52 weeks, we found a statistically
significant difference in recovery rate (52% vs. 35%; dif-
ference, 17 percentage points [CI, 0 to 31.4 percentage
points]) in favor of additional manipulative therapy. Ad-
justment for important prognostic factors (for example,
age, sex, treatment preference, and duration of symptoms)
did not change our results. However, we found a differen-
tial effect of individual manual therapists. The patient re-
covery rates for individual therapists varied from 14% to
67% at the end of the intervention period, regardless of
prognostic status or the number of patients treated. Anal-
ysis of the treatment registration forms showed that all
therapists treated within the boundaries of the protocol;
therefore, this variation is probably due to unfavorable
prognostic status among treated patients. Although such
differential effects across therapists reflect daily health care
practice, they probably caused us to underestimate the
overall effectiveness of manipulative therapy.
To our knowledge, this is the first trial to focus on the
effectiveness of adding manipulative therapy for the cervi-
cothoracic spine and the adjacent ribs to usual medical care
for treatment of shoulder symptoms. We did not deviate
from the original study design, which was published inde-
pendently of the study results (15). At randomization, the
treatment groups were similar in demographic and patient
characteristics and putative prognostic indicators. Our
sample is comparable to those of other studies examining
shoulder symptoms in general practice (3, 14). To improve
the transparency of the contrasted treatments, we used spe-
cific protocols for both usual medical care and manipula-
tive therapy. Protocols for manipulative therapy focused on
a limited number of manipulative and mobilizing tech-
niques that target prespecified bones and joints.
Because of the open nature of manipulative therapy,
blinding of patients, general practitioners, and physical
therapists was not possible. Lack of blinding among pa-
tients could have caused ascertainment bias. Patients’ treat-
ment preferences could have influenced their responses re-
garding subjective outcome measures (25). Therefore,
patients who were a priori unwilling to adhere to allocated
treatments and those who had an absolute preference for or
against manipulative therapy were excluded. In addition,
our analyses showed that treatment preferences did not
affect patient-perceived recovery. Lack of blinding of gen-
eral practitioners and manual therapists could have reduced
the comparability of usual medical care. However, the
number and content of general practitioner sessions were
similar for both groups.
Because recruitment yield was lower than expected, we
decided to extend the inclusion period by 6 months, which
allowed us to include 150 patients instead of the intended
250 patients. We decided to stop recruitment because of
time and budget constraints. Neither decision was sup-
ported by interim analysis. Before the start of the study, we
considered a difference of 20 percentage points in favor of
manipulative therapy to be clinically relevant (15); the re-
ported difference in recovery of 22 percentage points is in
line with our expectations. However, we anticipated a re-
covery rate of 50% in patients who received usual medical
care, twice as high as the actual rate observed. In addition,
although we expected that 10% of patients would be lost
to follow-up, only 3 patients discontinued the allocated
manipulative therapy. The amount of missing data due to
attrition is limited and appears to be completely random.
Because fewer patients in the control group recovered and
adherence to allocated treatments and follow-up was high,
we reached sufficient statistical power with a smaller-than-
planned study sample.
Our trial was necessarily designed using open-label
treatment. Therefore, discontinuation of treatment and at-
trition may have biased our results (26). However, patients
with missing values were equally distributed between treat-
ment groups, and there were no indications that treatment
discontinuation and attrition were related to prognostic
status or treatment allocation or outcome. Imputation of
missing values according to the last-observation-carried-
forward method and the baseline-value-carried-forward
method yielded similar results. However, missing values for
outcome measures may have made our results less precise.
Manipulative therapy for treatment of shoulder symp-
toms is rarely studied. Our findings corroborate the find-
ings of the previous study by Winters and colleagues (13,
14), which found that manipulative therapy for the shoul-
der girdle yielded considerable benefit compared with
physiotherapy. We demonstrated that manipulative ther-
apy for the shoulder girdle in addition to usual medical
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care by a general practitioner accelerated recovery of shoul-
der symptoms and reduced their severity. These effects
were sustained at 52 weeks of follow-up. Compared with
the study by Winters and colleagues (13, 14), our study
included only patients with shoulder symptoms and dys-
function of the shoulder girdle. We also included more
patients, had nearly complete follow-up, and restricted ma-
nipulative therapy to avoid bias due to treatment contam-
ination.
We believe that general practitioners should include a
short physical examination of the shoulder girdle in their
structured medical examinations. For patients with shoul-
der symptoms in whom dysfunction of the cervicothoracic
spine and adjacent ribs is found, referral to a manual ther-
apist should be considered.
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